age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
71.745
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 16
|
$11-$25k
| 0
| 9,478
| 5,019.3398
| null | 14
|
white
| 23.898438
| 38
| 0.78894
| 0.660889
| 1
| 1
| 0
|
no
| 0.95
| 0.8
|
dnr after sadm
| 1
| 53
| 11.5
| 82
| 20
| 36.39844
| null | null | null | 2.099609
| 139
| null | null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.544922
| 328
| 1
|
65.93298
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 13
|
under $11k
| 0
| 10,227
| 5,117.5234
| null | 10
|
asian
| 20.796875
| 30
| 0.810913
| 0.69397
| 8
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 4
| 103
| 8.699219
| 134
| 24
| 36
| 260.8125
| null | null | 1
| 141
| 7.459961
| null | null | null | null | 3
|
no(M2 and SIP pres)
| 3
| 715
| 1
|
69.98199
|
female
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 100
| 65,732
| 33,516.375
| null | 34
|
black
| 28
| 43
| 0.217987
| 0.069992
| 3
| 0
| 0
|
no
| 0.06
| 0.000216
|
no dnr
| 15
| 63
| 11.199219
| 110
| 26
| 36.5
| 241.65625
| 3.299805
| 2.699707
| 1.5
| 130
| 7.389648
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 680
| 1
|
82.14099
|
male
| 0
| 20
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 26
| 113,460
| 56,403.9375
| null | 15
|
black
| 23
| 32
| 0.402954
| 0.283997
| 12
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
dnr after sadm
| 12
| 75
| 9.199219
| 70
| 22
| 36.5
| 107.14062
| 3.599609
| 0.299988
| 1.299805
| 133
| 7.5
| null | null | null | null | null | null | 4.479492
| 65
| 1
|
41.06198
|
female
| 0
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
|
$11-$25k
| 0
| 16,536
| 8,055.3008
| null | 6
|
black
| 18.898438
| 9
| 0.914917
| 0.883911
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 4
| 117
| 16.898438
| 74
| 24
| 37
| 218.34375
| null | null | 1
| 130
| 7.379883
| null | null | null | null | null | null | 2.039551
| 1,419
| 0
|
56.34998
|
female
| 0
| 3
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 4,944
| 2,253.7129
| null | 6
|
white
| 20.597656
| 12
| 0.892944
| 0.820923
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 87
| 6.699219
| 100
| 24
| 37
| 266.625
| null | null | 0.599976
| 130
| 7.439453
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,344
| 1
|
67.72894
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 18
|
$11-$25k
| 0
| 32,258
| 16,843.2656
| null | 10
|
white
| 15.298828
| 20
| 0.897949
| 0.828979
| 1
| 0
| 0
|
no
| 0.96
| 0.92
|
no dnr
| 9
| 110
| 7.599609
| 65
| 24
| 36.5
| null | null | 0.799927
| 1.299805
| 137
| null | null | null | null | null | null | null | 2.985352
| 1,325
| 1
|
51.18698
|
male
| 0
| 10
|
Colon Cancer
|
Cancer
| 3
| null | null | 0
| 30,006
| 15,566.1562
| null | 11.5
|
white
| 23.097656
| 39
| 0.75293
| 0.493958
| 1
| 1
| 0
|
metastatic
| 0.1
| 0.001
|
no dnr
| 10
| 120
| 11.398438
| 140
| 20
| 39.5
| null | null | 0.299988
| 1.699951
| 135
| null | null | null | null | null | null | null | 3.51709
| 1,243
| 1
|
48.43799
|
male
| 1
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 15
|
>$50k
| 0
| 275,297
| 131,152.125
| null | 38.5
|
white
| 49.5
| 93
| 0.023998
| 0.006
| 27
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 9
| 58
| 0.599976
| 170
| 26
| 39.89844
| 56
| 2.599609
| 0.599976
| 3.599609
| 150
| 7.329102
| null | null | null | null | null |
<2 mo. follow-up
| 2.244629
| 11
| 1
|
63.573
|
female
| 1
| 32
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 26
| 231,839
| 99,332.375
| null | 30.75
|
white
| 34.898438
| 34
| 0.128998
| 0.058998
| 7
| 0
| 0
|
metastatic
| 0.75
| 0.2
|
dnr after sadm
| 18
| 60
| 4.099609
| 130
| 23
| 38.69531
| 107.6875
| 2
| 0.599976
| 0.899902
| 125
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 3.240234
| 32
| 1
|
56.74197
|
male
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| 18
|
$11-$25k
| 0
| 41,129
| 20,834.9062
| null | 12.5
|
white
| 5.199219
| 11
| 0.931885
| 0.839966
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.85
|
no dnr
| 12
| 98
| 10.599609
| 82
| 20
| 36.39844
| null | 4.399414
| 0.699951
| 1.099854
| 136
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 738
| 1
|
52.43799
|
male
| 0
| 17
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 73,122
| 36,176.8438
| null | 22.333328
|
white
| 19.296875
| 19
| 0.890991
| 0.816895
| 2
| 1
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 17
| 67
| 6.299805
| 110
| 22
| 36.39844
| 457.125
| null | null | 0.899902
| 134
| 7.489258
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,411
| 0
|
73.59094
|
female
| 0
| 124
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 37
| null | 352,231.25
| null | 34.25
|
white
| 30.398438
| 49
| 0.379944
| 0.261963
| 11
| 0
| 0
|
no
| null | null |
no dnr
| 124
| 68
| 27.5
| 110
| 12
| 38.5
| 90.90625
| 2.399902
| 2.399902
| 1.099854
| 131
| 7.419922
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.776367
| 200
| 1
|
56.50098
|
male
| 1
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 41
| 95,243
| 48,038.875
| null | 26.5
|
white
| 32.796875
| 54
| 0.22699
| 0.074997
| 15
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 7
| 123
| 16.898438
| 115
| 9
| 37
| 273.3125
| 3.599609
| 11.398438
| 5.899414
| 137
| 7.439453
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 7
| 1
|
45.22699
|
male
| 0
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 37
| 213,989
| 110,645.438
| null | 27.5
|
white
| 23.398438
| 21
| 0.754883
| 0.67688
| 4
| 0
| 0
|
no
| null | null |
no dnr
| 29
| 122
| 18.5
| 120
| 6
| 37.29688
| 504
| null | null | 0.699951
| 132
| 7.489258
| null | null | null | null | null | null | 3.437012
| 1,406
| 0
|
54.44498
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 18
|
>$50k
| 41
| 61,442
| 28,589.9844
| null | 42
|
white
| 58.695313
| 81
| 0.003
| 0
| 2
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 5
| 30
| 6.799805
| 145
| 20
| 39.19531
| 81
| 2.199707
| 12.699219
| 0.599976
| 131
| 7.349609
| null | null | null | null | null |
<2 mo. follow-up
| 2.519531
| 5
| 1
|
85.36096
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
| null | 100
| 51,486
| 24,927.7031
| null | 33
|
white
| 44.296875
| 76
| 0
| 0
| 9
| 0
| 0
|
no
| 0.01
| 0.000001
|
no dnr
| 3
| 40
| 18.097656
| 30
| 25
| 38
| 294
| null | 2.5
| 2.699707
| 131
| 7.229492
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 3
| 1
|
46.08099
|
male
| 0
| 31
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
under $11k
| 0
| 170,570
| 84,744.75
| null | 17
|
hispanic
| 15.099609
| 12
| 0.93689
| 0.891968
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 31
| 67
| null | 50
| 16
| 37.79688
| null | null | 0.199982
| 0.899902
| 138
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,405
| 0
|
32.42697
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
under $11k
| 100
| 382,471
| 201,105.75
| null | 45.5
|
white
| 43.09375
| 98
| 0.045998
| 0.014
| 13
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 9
| 57
| 39.796875
| 120
| 36
| 35.09375
| 205.6875
| 1.799805
| 16.898438
| 2.199707
| 134
| 7.399414
| null | null | null | null | null |
<2 mo. follow-up
| 4.032227
| 10
| 1
|
66.27496
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 20
|
>$50k
| 0
| 18,606
| 9,488.0312
| null | 9
|
white
| 18.597656
| 11
| 0.791992
| 0.56189
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 8
| 83
| 13.398438
| 68
| 20
| 38
| null | 3.199707
| 1.399902
| 1.099854
| 135
| null | null | null | null | 0
| null | null | 0.4948
| 879
| 1
|
78.53796
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$25-$50k
| 0
| 8,697
| 5,066.1602
| null | 7
|
white
| 21.097656
| 28
| 0.775879
| 0.641968
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 6
| 96
| 12.199219
| 96
| 22
| 36
| 157.125
| 3.699707
| 0.599976
| 1.199951
| 142
| 7.399414
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 146
| 1
|
50.95099
|
female
| 1
| 43
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
| null | 26
| 449,923
| 199,117.25
| null | 41.75
|
black
| 27.296875
| 47
| 0.530884
| 0.415955
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 43
| 63
| 19.398438
| 125
| 14
| 39.39844
| 234
| 2.899902
| 1.399902
| 6.599609
| 144
| 7.40918
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 43
| 1
|
39.81897
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 13
| null | 100
| 54,871
| 26,152.2031
| null | 40
|
white
| 60.5
| 102
| 0
| 0
| 3
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 5
| 35
| 18.398438
| 130
| 15
| 38.79688
| 100
| 2.099609
| 20.296875
| 3
| 132
| 7.30957
| null | null | null | null | null |
<2 mo. follow-up
| 3.381348
| 5
| 1
|
31.34299
|
female
| 1
| 11
|
Coma
|
Coma
| 1
| null | null | 100
| 148,727
| 66,520.625
| null | 28
|
white
| 47.59375
| 62
| 0
| 0
| 32
| 0
| 0
|
metastatic
| null | null |
no dnr
| 11
| 42
| 20.199219
| 140
| 20
| 38.5
| 68
| null | null | 2.299805
| 132
| 7.339844
| null | null | null | null | null |
<2 mo. follow-up
| 3.606934
| 11
| 1
|
73.14697
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 4
|
>$50k
| 0
| 20,810
| 13,290.375
| null | 9.5
|
white
| 21
| 39
| 0.823975
| 0.712891
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 70
| 8.599609
| 65
| 28
| 36
| null | null | null | 2
| 138
| null | null | null | null | null | 4
|
no(M2 and SIP pres)
| 4
| 971
| 1
|
73.70294
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 24
| null | 0
| 14,284
| 8,644.1797
| null | 8
|
white
| 20.296875
| 45
| 0.830933
| 0.723999
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 77
| 5.299805
| 92
| 28
| 38.09375
| 261.875
| null | 2.299805
| 2.199707
| 137
| 7.479492
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 166
| 1
|
71.75397
|
female
| 0
| 25
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 9
|
under $11k
| 26
| 135,615
| 60,638.9062
| null | 22.5
|
black
| 18.097656
| 15
| 0.794922
| 0.670898
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 25
| 60
| 15.398438
| 110
| 10
| 38.19531
| 300
| 2.799805
| null | 0.899902
| 137
| 7.439453
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.896973
| 1,400
| 0
|
63.59799
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 44
| 51,942
| 23,758.9062
| null | 39
|
white
| 69.390625
| 100
| 0
| 0
| 1
| 0
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 2
| 30
| 50.59375
| 115
| 25
| 38.39844
| 56
| 2.5
| 22.796875
| 5.199219
| 129
| 7.579102
| null | null | null | null | null |
<2 mo. follow-up
| 2.206543
| 4
| 1
|
72.323
|
male
| 0
| 18
|
Colon Cancer
|
Cancer
| 2
| null | null | 0
| 36,244
| 20,509.875
| null | 11.333328
|
white
| 28.597656
| 19
| 0.569946
| 0.247986
| 1
| 1
| 0
|
metastatic
| 0.6
| 0.2
|
dnr after sadm
| 9
| 81
| 16.296875
| 112
| 20
| 39.19531
| null | 3.099609
| null | 0.799927
| 128
| null | null | null | null | null | null | null | 3.349121
| 66
| 1
|
44.12299
|
female
| 0
| 28
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
| null | 41
| 293,158
| 148,681.25
| null | 19.25
|
white
| 37.59375
| 71
| 0.084
| 0.031998
| 23
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 28
| 63
| 3.399902
| 160
| 21
| 39.19531
| 348
| null | 9
| 4.899414
| 135
| 7.40918
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 55
| 1
|
21.74899
|
male
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
under $11k
| 0
| 156,314
| 88,603.3125
| null | 26.333328
|
white
| 19.898438
| 11
| 0.92395
| 0.896973
| 4
| 0
| 0
|
no
| null | null |
no dnr
| 23
| 70
| 10.798828
| 105
| 20
| 38.59375
| 206.09375
| null | null | 0.799927
| 145
| 7.30957
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,396
| 0
|
67.85797
|
female
| 1
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
>$50k
| 0
| 234,034
| 109,152.25
| null | 37.666657
|
white
| 21.898438
| 34
| 0.771973
| 0.697998
| 13
| 0
| 0
|
no
| 0.8
| 0.75
|
dnr after sadm
| 17
| 75
| 6.599609
| 105
| 28
| 36.5
| 183.3125
| 2.099609
| null | 1
| 144
| 7.489258
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
58.05099
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 12
| null | 0
| 9,864
| 5,061.0352
| null | 9
|
black
| 16.5
| 12
| 0.733887
| 0.464966
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.75
|
no dnr
| 6
| 79
| 10.298828
| 100
| 24
| 37.39844
| null | null | null | 0.899902
| 137
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.530273
| 1,395
| 0
|
57.84799
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 55
| 139,623
| 68,361.5
| null | 58
|
white
| 57.796875
| 104
| 0
| 0
| 18
| 0
| 0
|
yes
| 0.07
| 0.000343
|
no dnr
| 4
| 48
| 0.049995
| 200
| 32
| 39.29688
| 75.54688
| null | 8.699219
| 1.799805
| 152
| 7.289062
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 4
| 1
|
72.56097
|
male
| 1
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$25-$50k
| 9
| 301,990
| 138,869.5
| null | 26.5
|
white
| 38.898438
| 57
| 0.181
| 0.093994
| 21
| 0
| 0
|
yes
| 0.5
| 0.125
|
dnr after sadm
| 22
| 70
| 15.798828
| 110
| 22
| 36.09375
| 190
| 3.299805
| 26.296875
| 2.399902
| 135
| 7.469727
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 28
| 1
|
49.53
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 10,545
| 5,904.1562
| null | 10
|
black
| 15.699219
| 21
| 0.927979
| 0.878906
| 1
| 1
| 0
|
no
| 1
| 0.95
|
no dnr
| 4
| 103
| 6.199219
| 86
| 24
| 36.89844
| null | null | null | 1.399902
| 134
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.237305
| 1,392
| 0
|
60.65399
|
male
| 1
| 51
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 26
| 475,387
| 216,298.25
| null | 35.75
|
white
| 30.5
| 52
| 0.615967
| 0.510986
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 44
| 63
| 5.199219
| 125
| 8
| 38.89844
| 114
| 2.399902
| 1.5
| 1.799805
| 137
| 7.399414
| null | null | null | null | null |
<2 mo. follow-up
| 3.022461
| 51
| 1
|
69.41797
|
male
| 1
| 4
|
Lung Cancer
|
Cancer
| 1
| 14
|
$11-$25k
| 0
| 7,194
| 3,058.4688
| null | 12
|
asian
| 26.898438
| 33
| 0.445984
| 0.134979
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 2
| 73
| null | 62
| 34
| 39.19531
| 128.5625
| 3.099609
| 0.299988
| 1.099854
| 133
| 7.479492
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 4
| 1
|
25.89699
|
male
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 251,227
| 126,467.875
| null | 22.5
|
hispanic
| 33
| 36
| 0.691895
| 0.600952
| 16
| 0
| 0
|
yes
| 0.75
| 0.7
|
no dnr
| 28
| 153
| 7.099609
| 110
| 24
| 35.89844
| 76
| 2.799805
| 0.799927
| 2.199707
| 136
| 7.389648
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 1,391
| 0
|
47.43298
|
male
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
$11-$25k
| 26
| 169,364
| 82,586.5
| null | 37
|
white
| 33.796875
| 63
| 0.612915
| 0.507935
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 6
| 73
| 5.099609
| 115
| 24
| 36.89844
| 191.65625
| 2.199707
| 19.296875
| 1.699951
| 141
| 7.519531
| null | null | null | null | null |
<2 mo. follow-up
| 3.063965
| 17
| 1
|
36.29797
|
male
| 0
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 48,925
| 26,166.5
| null | 10
|
white
| 23.597656
| 18
| 0.845947
| 0.746948
| 2
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 15
| 97
| 13.5
| 118
| 16
| 38
| 190
| null | 3.199707
| 0.799927
| 140
| 7.389648
| null | null | null | 0
| null | null | 0.4948
| 1,385
| 0
|
63.07999
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
under $11k
| 0
| 29,706
| 14,753.0078
| null | 13.5
|
hispanic
| 31
| 44
| 0.705933
| 0.544922
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 9
| 51
| 5.299805
| 75
| 24
| 36.29688
| null | 2.5
| 1.199951
| 1.299805
| 128
| 7.469727
| null | null | null | 1
| 3
|
no(M2 and SIP pres)
| 3
| 1,384
| 0
|
61.77399
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
>$50k
| 0
| 21,076
| 12,039.4688
| null | 16
|
white
| 13.699219
| 16
| 0.919922
| 0.86499
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 9
| 110
| 6
| 70
| 16
| 36.59375
| null | 3.599609
| 0.699951
| 1.299805
| 141
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 181
| 1
|
55.23297
|
female
| 1
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 9
| 233,772
| 97,798.75
| null | 39.666657
|
other
| 27.5
| 34
| 0.763916
| 0.688965
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 19
| 60
| 11.298828
| 115
| 8
| 36.39844
| 230
| 2.799805
| 0.799927
| 1.399902
| 125
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 2.753906
| 19
| 1
|
72.42694
|
female
| 1
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| null | null | 26
| 69,587
| 34,518
| null | 37.5
|
other
| 29.097656
| 47
| 0.326965
| 0.142975
| 2
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 8
| 103
| 8.398438
| 135
| 32
| 37.69531
| 172.5
| 3.099609
| 4.699219
| 1.299805
| 153
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 3.146973
| 9
| 1
|
80.38599
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 2
| 8
|
$25-$50k
| 0
| 11,109
| 6,680.4805
| null | 9
|
white
| 15.398438
| 25
| 0.810913
| 0.594971
| 1
| 1
| 0
|
metastatic
| 0.9
| 0.3
|
no dnr
| 5
| 73
| 5.599609
| 72
| 18
| 36.19531
| null | null | null | 1.099854
| 135
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 215
| 1
|
74.12695
|
male
| 1
| 3
|
Coma
|
Coma
| 1
| 14
|
under $11k
| 100
| 22,541
| 11,522.2422
| null | 24
|
white
| 22.398438
| 13
| 0.166992
| 0.112
| 1
| 0
| 1
|
no
| null | null |
dnr after sadm
| 3
| 82
| 9.699219
| 50
| 14
| 35
| 430
| 4.099609
| null | 0.899902
| 134
| 7.479492
| null | null | null | null | null |
<2 mo. follow-up
| 4.672852
| 3
| 1
|
34.32199
|
female
| 0
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
|
$11-$25k
| 55
| 271,769
| 136,256.625
| null | 26.5
|
hispanic
| 28.597656
| 39
| 0.638916
| 0.537964
| 4
| 1
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 40
| 115
| 13.199219
| 110
| 16
| 39.5
| 166.65625
| null | 0.699951
| 7.399414
| 136
| 7.359375
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 150
| 1
|
51.491
|
female
| 1
| 90
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
$11-$25k
| 37
| 1,056,280
| 463,356.75
| null | 38
|
white
| 36
| 59
| 0.395996
| 0.276978
| 6
| 0
| 0
|
no
| null | null |
dnr after sadm
| 88
| 63
| 39
| 135
| 36
| 37.09375
| 220
| null | 2.699707
| 3.699707
| 129
| 7.5
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 90
| 1
|
64.92499
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 5
| null | 0
| 22,303
| 10,978.2969
| null | 23
|
hispanic
| 21.699219
| 29
| 0.842896
| 0.741943
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 6
| 60
| 7.5
| 135
| 28
| 36.39844
| 258.3125
| null | 0.699951
| 0.799927
| 142
| 7.329102
| null | null | null | 3
| 3
| null | 3
| 1,378
| 0
|
71.95599
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| null | null | 0
| 35,928
| 18,626.0938
| null | 18.5
|
asian
| 24.5
| 38
| 0.779907
| 0.647949
| 1
| 0
| 0
|
no
| 0.95
| 0.6
|
no dnr
| 10
| 55
| 6.199219
| 105
| 24
| 39.19531
| null | null | 1.199951
| 1.899902
| 133
| null | null | null | null | null | null | null | 2.697266
| 137
| 1
|
60.59097
|
female
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 35,397
| 18,058.4375
| null | 12.5
|
white
| 4.299805
| 17
| 0.93396
| 0.843994
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.8
|
no dnr
| 12
| 81
| 7.5
| 120
| 22
| 38.39844
| null | 4.699219
| 0.5
| 1
| 139
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,376
| 0
|
33.09
|
male
| 1
| 24
|
MOSF w/Malig
|
ARF/MOSF
| 0
| null | null | 55
| 216,416
| 96,186.9375
| null | 31.666656
|
asian
| 37.296875
| 37
| 0.082993
| 0.031998
| 7
| 0
| 0
|
yes
| 0.1
| 0.001
|
no dnr
| 24
| 110
| 3
| 160
| 12
| 35.5
| 113.84375
| null | 0.5
| 0.5
| 135
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 2.698242
| 24
| 1
|
74.74896
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 10,758
| 4,629.7305
| null | 6
|
white
| 16.796875
| 38
| 0.866943
| 0.779907
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 4
| 65
| 5
| 110
| 24
| 36
| null | 5.5
| 0.799927
| 1.5
| 130
| null | null | null | null | null | null | null | 2.025391
| 473
| 1
|
50.90198
|
male
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$25-$50k
| 0
| 37,558
| 23,093.8125
| null | 15.5
|
white
| 16.398438
| 21
| 0.921997
| 0.86792
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 13
| 68
| 11
| 110
| 20
| 37.79688
| null | 4.199219
| 1.399902
| 1.299805
| 132
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 790
| 1
|
55.866
|
male
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$25-$50k
| 0
| 68,122
| 30,441.1719
| null | 14
|
white
| 20
| 40
| 0.885986
| 0.80896
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 14
| 70
| 22.597656
| 140
| 20
| 36
| null | 4.699219
| 1.099854
| 1.899902
| 138
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 783
| 1
|
77.396
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$25-$50k
| 0
| 9,246
| 5,969.9688
| null | 10
|
white
| 13.398438
| 16
| 0.891968
| 0.81897
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 6
| 80
| 9.298828
| 80
| 20
| 37.09375
| 357.125
| null | 0.399963
| 1.299805
| 137
| 7.469727
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,375
| 0
|
63.017
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
$25-$50k
| 26
| 133,878
| 63,155.6875
| null | 16.666656
|
white
| 20.5
| 25
| 0.759888
| 0.68396
| 5
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 14
| 57
| 6.899414
| 80
| 8
| 37.19531
| 144
| 2.599609
| 0.899902
| 0.899902
| 137
| 7.449219
| null | null | null | 0
| null | null | 0.4948
| 1,374
| 0
|
41.974
|
male
| 0
| 53
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 328,134
| null | null | 35.5
|
white
| 53.695313
| 73
| 0.21698
| 0.120987
| 1
| 0
| 0
|
no
| 0.4
| 0.4
|
no dnr
| 53
| 50
| 5.699219
| 135
| 30
| 35.09375
| 56
| 2.799805
| 5.599609
| 3.099609
| 142
| 7.40918
| null | null | null | null | null | null | 2.099609
| 1,373
| 0
|
67.88495
|
male
| 1
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 18
|
$25-$50k
| 26
| 181,177
| 83,650.4375
| null | 25
|
white
| 24.597656
| 33
| 0.664917
| 0.567993
| 4
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 24
| 73
| 25.796875
| 110
| 22
| 36.39844
| 230
| 2.799805
| 1.799805
| 1.399902
| 131
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 2.439941
| 24
| 1
|
46.48297
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 37
| 95,454
| 46,194.7812
| null | 17.333328
|
white
| 22.398438
| 35
| 0.759888
| 0.68396
| 5
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 16
| 75
| 10.298828
| 130
| 48
| 38
| 427
| null | null | 0.799927
| 141
| 7.30957
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.946777
| 1,373
| 0
|
64.51697
|
male
| 0
| 17
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 9
|
under $11k
| 0
| 125,379
| 72,966.375
| null | 24.666656
|
white
| 21.597656
| 22
| 0.809937
| 0.692993
| 6
| 0
| 0
|
no
| null | null |
no dnr
| 17
| 67
| 8.398438
| 100
| 24
| 36
| null | null | null | 1.299805
| 129
| null | null | null | null | 0
| null |
SIP>=30
| 0.4948
| 249
| 1
|
65.711
|
female
| 0
| 44
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
>$50k
| 0
| 497,053
| 228,884.625
| null | 38.75
|
white
| 37.59375
| 60
| 0.422974
| 0.302979
| 9
| 0
| 0
|
no
| null | null |
no dnr
| 44
| 50
| 13.699219
| 95
| 12
| 38.5
| 106.65625
| 3.599609
| 2.399902
| 5
| 144
| 7.5
| null | null | null | null | 0
| null | 0
| 394
| 1
|
73.42896
|
male
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
>$50k
| 0
| 79,641
| 39,536.7812
| null | 30
|
white
| 26.097656
| 33
| 0.745972
| 0.599976
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 14
| 53
| 19.398438
| 80
| 20
| 36.39844
| 155.09375
| null | null | 1.399902
| 137
| 7.259766
| null | null | null | null | 1
| null | 1
| 413
| 1
|
34.05899
|
female
| 0
| 36
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
under $11k
| 0
| 250,630
| 105,455.062
| null | 23.25
|
black
| 22.199219
| 11
| 0.895996
| 0.85791
| 2
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 36
| 103
| 21.898438
| 105
| 18
| 38.79688
| 257.5
| null | null | 0.5
| 133
| 7.469727
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,368
| 0
|
32.40198
|
female
| 1
| 18
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 17
|
$25-$50k
| 44
| 262,612
| 123,059.438
| null | 33.666657
|
white
| 46.59375
| 69
| 0.007999
| 0.001
| 12
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 8
| 107
| 13.099609
| 120
| 28
| 36.79688
| 142.5
| null | 36
| 3.899902
| 142
| 7.509766
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 18
| 1
|
28.30099
|
male
| 0
| 37
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 194,198
| 119,175.312
| null | 15.5
|
white
| 22.097656
| 30
| 0.924927
| 0.872925
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 37
| 67
| 6.299805
| 135
| 16
| 36.29688
| null | null | null | 1.599854
| 139
| null | null | null | null | null | null | null | 2.690918
| 1,366
| 0
|
56.323
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 100
| 151,266
| 68,650.875
| null | 32
|
white
| 73.1875
| 82
| 0
| 0
| 14
| 1
| 0
|
no
| null | null |
no dnr
| 3
| 0
| 15.398438
| 135
| 10
| 38.5
| 142
| null | null | 3.199707
| 132
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 2.596191
| 3
| 1
|
47.98099
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| 18
| null | 0
| null | null | null | 9
|
white
| 16.5
| 12
| 0.754883
| 0.497986
| 1
| 0
| 0
|
metastatic
| null | null | null | null | 72
| 8.298828
| 100
| 20
| 37.19531
| null | null | null | 0.799927
| 136
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.524902
| 1,364
| 0
|
70.125
|
female
| 1
| 11
|
Coma
|
Coma
| 0
| null | null | 55
| 96,471
| 46,450.0938
| null | 40.5
|
white
| 30
| 47
| 0.210999
| 0.148987
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 9
| 122
| 37
| 135
| 28
| 38.5
| 113.32812
| null | null | 1.199951
| 140
| 7.539062
| null | null | null | null | null |
<2 mo. follow-up
| 2.359863
| 11
| 1
|
35.31799
|
female
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 37
| 212,409
| 97,678.0625
| null | 35.666657
|
black
| 33.898438
| 36
| 0.609985
| 0.503906
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 18
| 70
| 11
| 130
| 22
| 38.89844
| 37
| null | 1.199951
| 0.799927
| 134
| 7.199219
| null | null | null | null | null |
<2 mo. follow-up
| 2.666016
| 18
| 1
|
52.827
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 14
|
>$50k
| 44
| 116,166
| 56,024.5312
| null | 29.5
|
white
| 39.695313
| 74
| 0.232971
| 0.132996
| 7
| 0
| 0
|
no
| null | null |
dnr after sadm
| 6
| 53
| 12.398438
| 110
| 24
| 39.5
| null | null | 25.597656
| 7.799805
| 145
| null | null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 8
| 1
|
68.64899
|
male
| 0
| 20
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 18
|
$11-$25k
| 0
| 75,142
| 37,775.2188
| null | 15.666664
|
white
| 35
| 50
| 0.578979
| 0.384949
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 20
| 65
| 20.796875
| 120
| 30
| 35.79688
| 253.03125
| null | 0.5
| 3.299805
| 127
| 7.429688
| null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 45
| 1
|
69.52795
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 17
|
>$50k
| 26
| 122,312
| 61,386.375
| null | 17.333328
|
white
| 25.898438
| 39
| 0.598999
| 0.490967
| 8
| 0
| 0
|
no
| null | null |
no dnr
| 14
| 68
| 19.398438
| 110
| 40
| 39.5
| 295
| 2.199707
| 0.399963
| 0.599976
| 131
| 7.549805
| null | null | null | null | 0
|
SIP>=30
| 0
| 1,361
| 0
|
63.05798
|
male
| 0
| 71
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 37
| 600,192
| 274,269.75
| null | 45.5
|
white
| 32.695313
| 62
| 0.41095
| 0.291992
| 6
| 1
| 0
|
no
| null | null |
no dnr
| 71
| 52
| 10.699219
| 120
| 38
| 39.09375
| 198
| null | null | 2.099609
| 140
| 7.449219
| null | null | null | null | null | null | 3.199707
| 1,016
| 1
|
66.09198
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 18
|
>$50k
| 0
| 8,272
| 3,430.8106
| null | 11
|
asian
| 17
| 11
| 0.704956
| 0.419983
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.25
|
no dnr
| 4
| 83
| 6.299805
| 90
| 20
| 36.59375
| null | null | null | 0.799927
| 132
| null | null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 54
| 1
|
70.48297
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
| null | 0
| 19,065
| 10,006.6484
| null | 13.5
|
white
| 24.199219
| 31
| 0.78894
| 0.661987
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 9
| 53
| 6.899414
| 110
| 22
| 36.19531
| null | null | 1
| 0.899902
| 134
| null | null | null | null | null | 1
| null | 1
| 670
| 1
|
60.98599
|
female
| 0
| 82
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 864,424
| null | null | 32.75
|
white
| 19.699219
| 33
| 0.684937
| 0.591919
| 49
| 0
| 0
|
yes
| null | null |
no dnr
| 82
| 70
| 8.298828
| 115
| 26
| 38.19531
| 187.5
| 2.299805
| 0.799927
| 0.899902
| 136
| 7.5
| null | null | null | null | null | null | 2.479981
| 433
| 1
|
85.862
|
female
| 1
| 57
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null |
$11-$25k
| 0
| 329,169
| 131,754.125
| null | 30.75
|
white
| 33.898438
| 52
| 0.396973
| 0.199982
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 128
| 11.298828
| 155
| 14
| 36.19531
| 155
| 2.699707
| null | 1.799805
| 137
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 3.770508
| 57
| 1
|
59.81097
|
female
| 0
| 63
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 44
| 401,801
| 180,741.5
| null | 34.75
|
black
| 30.097656
| 47
| 0.471985
| 0.352966
| 6
| 0
| 0
|
no
| 0.15
| 0.1
|
no dnr
| 63
| 93
| 28.296875
| 140
| 30
| 38.5
| 147.5
| 1.799805
| 0.699951
| 0.799927
| 129
| 7.469727
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 232
| 1
|
56.65399
|
female
| 0
| 15
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 61,711
| 29,678.0781
| null | 24.666656
|
black
| 8.699219
| 20
| 0.910889
| 0.792969
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.7
|
no dnr
| 15
| 80
| 6.799805
| 116
| 24
| 38.39844
| null | 3.599609
| 4.699219
| 0.899902
| 136
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.257324
| 1,355
| 0
|
82.086
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 22,899
| 11,851.4297
| null | 12.5
|
other
| 27.199219
| 46
| 0.67688
| 0.506958
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 55
| 6.799805
| 120
| 24
| 36.29688
| null | null | null | 2.099609
| 135
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 3.915039
| 1,354
| 0
|
33.5
|
female
| 0
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 158,358
| 76,204.125
| null | 11.5
|
hispanic
| 20
| 26
| 0.912964
| 0.880981
| 2
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 33
| 117
| 15.699219
| 76
| 34
| 36.19531
| 280
| 1.599854
| 0.199982
| 0.899902
| 130
| 7.379883
| null | null | null | 5
| 0
|
SIP>=30
| 0
| 1,353
| 0
|
72.84094
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 10,314
| 5,952.375
| null | 9
|
white
| 18.699219
| 15
| 0.652954
| 0.347961
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 4
| 87
| 5.5
| 80
| 18
| 36
| null | null | 1.099854
| 1.099854
| 129
| null | null | null | null | null | null | null | 2.465332
| 541
| 1
|
78.43695
|
female
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
| null | 61
| 106,126
| 48,244.8438
| null | 45.5
|
white
| 29.199219
| 34
| 0.313965
| 0.200989
| 3
| 0
| 0
|
no
| 0.3
| 0.2
|
no dnr
| 12
| 67
| 11.199219
| 60
| 24
| 38.39844
| 71.26562
| null | 0.799927
| 1
| 128
| 7.329102
| null | null | null | null | null |
<2 mo. follow-up
| 3.557617
| 12
| 1
|
78.00995
|
male
| 0
| 52
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 298,193
| 133,595.625
| null | 25.75
|
white
| 20.296875
| 31
| 0.671997
| 0.575928
| 11
| 0
| 0
|
no
| null | null |
no dnr
| 52
| 70
| 7.799805
| 110
| 34
| 38.69531
| 267.5
| null | null | 0.899902
| 130
| 7.459961
| null | null | null | null | null | null | 2.775879
| 969
| 1
|
67.92596
|
female
| 0
| 11
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 30,406
| 15,743.8906
| null | 19
|
white
| 11.599609
| 24
| 0.873901
| 0.715942
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.8
|
no dnr
| 11
| 108
| 28.199219
| 108
| 20
| 36.59375
| null | 3.299805
| 2.099609
| 0.699951
| 137
| null | null | null | null | null | null | null | 2.393555
| 1,000
| 1
|
68.55597
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$25-$50k
| 0
| 11,855
| 6,571.6523
| null | 8
|
white
| 21
| 23
| 0.839966
| 0.737915
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 93
| 7.699219
| 100
| 22
| 35.89844
| 295.1875
| null | null | 1.899902
| 139
| 7.429688
| null | null | null | null | null | null | 2.421875
| 923
| 1
|
68.68195
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 8,686
| 4,529.3477
| null | 8
|
white
| 25.398438
| 29
| 0.491943
| 0.172974
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 83
| 1.599854
| 100
| 24
| 36.39844
| null | 3
| 0.599976
| 2
| 138
| null | null | null | null | null | null | null | 2.617188
| 222
| 1
|
33.01297
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 26
| 77,603
| 40,723.6875
| null | 23
|
white
| 23
| 55
| 0.845947
| 0.792969
| 2
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 12
| 133
| 10.5
| 100
| 8
| 38.19531
| 194
| null | 0.5
| 10.798828
| 146
| 7.439453
| null | null | null | null | null | null | 2.748535
| 68
| 1
|
55.96399
|
male
| 0
| 22
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 14
|
$25-$50k
| 0
| 193,362
| 100,574.375
| null | 20.666656
|
white
| 22
| 26
| 0.671997
| 0.5
| 7
| 0
| 0
|
yes
| 0.8
| 0.6
|
no dnr
| 22
| 77
| 12.898438
| 110
| 24
| 39
| null | null | 3.699707
| 0.899902
| 146
| null | null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,346
| 0
|
79.45496
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
>$50k
| 0
| 13,703
| 8,028.125
| null | 6
|
white
| 17.898438
| 16
| 0.841919
| 0.73999
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 80
| 6.5
| 50
| 16
| 36.29688
| null | null | null | 1.199951
| 137
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 636
| 1
|
60.37198
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 18
|
$25-$50k
| 37
| 234,608
| 110,586.75
| null | 33.333313
|
white
| 17.398438
| 40
| 0.780884
| 0.709961
| 7
| 0
| 0
|
no
| 0.85
| 0.85
|
no dnr
| 20
| 132
| 7.799805
| 110
| 10
| 38.39844
| 272.6875
| 2
| 3
| 1.199951
| 136
| 7.459961
| null | null | null | null | 0
| null | 0
| 1,344
| 0
|
71.65796
|
female
| 1
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 37
| 477,929
| 214,188.625
| null | 41.5
|
white
| 36.195313
| 55
| 0.197998
| 0.105988
| 33
| 0
| 0
|
no
| null | null |
dnr after sadm
| 24
| 52
| 14
| 110
| 12
| 36.89844
| 152
| null | null | 4.199219
| 143
| 7.459961
| null | null | null | null | null |
<2 mo. follow-up
| 2.786133
| 28
| 1
|
95.66095
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 10
| null | 9
| 12,435
| 6,208.4922
| null | 14
|
white
| 17.796875
| 31
| 0.756958
| 0.615967
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 89
| 11.599609
| 84
| 36
| 38
| 262.9375
| 3.199707
| 0.799927
| 1.099854
| 144
| 7.419922
| null | null | null | null | 4
| null | 4
| 661
| 1
|
61.88098
|
male
| 1
| 55
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 44
| 777,314
| 365,120.5
| null | 48.25
|
white
| 37.195313
| 78
| 0.197998
| 0.105988
| 38
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 31
| 60
| 19.796875
| 140
| 30
| 39
| 114
| 2.199707
| 1.199951
| 2.799805
| 131
| 7.239258
| null | null | null | null | null |
<2 mo. follow-up
| 3.333496
| 55
| 1
|
72.35297
|
female
| 1
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 13
|
$11-$25k
| 100
| 25,184
| 11,041.5938
| null | 39
|
white
| 38.398438
| 40
| 0.037994
| 0.003
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 48
| 7.299805
| 0
| 12
| 37.19531
| 388
| 3.199707
| 1.299805
| 1.399902
| 129
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 3.769531
| 3
| 1
|
57.93597
|
male
| 1
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 29,521
| 16,122.7266
| null | 16.5
|
white
| 30.398438
| 55
| 0.598999
| 0.408997
| 1
| 0
| 0
|
no
| 0.3
| 0.1
|
dnr after sadm
| 4
| 73
| 11.798828
| 108
| 20
| 36.59375
| 523.75
| 2.299805
| 11.798828
| 1.599854
| 130
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 3.885254
| 8
| 1
|
47.82498
|
male
| 0
| 12
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 14
|
under $11k
| 0
| 29,605
| 17,551.2656
| null | 12.5
|
white
| 15.898438
| 10
| 0.889893
| 0.815918
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 12
| 84
| 2.899902
| 80
| 16
| 35.59375
| 380
| 2.799805
| 0.399963
| 0.799927
| 140
| 7.439453
| null | null | null | 0
| null | null | 0.4948
| 889
| 1
|
70.14899
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 12,331
| 7,431.0938
| null | 10
|
white
| 15.898438
| 17
| 0.886963
| 0.810913
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 73
| 7.599609
| 90
| 18
| 36
| null | null | 1.099854
| 1.099854
| 140
| null | null | null | null | null | null | null | 2.080078
| 684
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.